Skip Navigation

ALS News

field with sun shining

Breaking Research

Apr 27
ALS Headlines, Breaking Research
Drug’s development stemmed from collaborative research from Packard Center investigators.
Feb 3
Breaking Research, Packard Center News
A Pathway to Discovery and Hope for ALS Patients and Researchers: A massive biological genetic and clinical resource for ALS and neurodegenerative diseases.
Jul 28
ALS Headlines, Breaking Research, Packard Center News
Packard researchers used Answer ALS cell lines to show that the protein CHMP7 accumulates in the nucleus, triggering a series of events that creates some of the molecular hallmarks found in both sporadic and familial ALS as well as FTD.
Jan 8
ALS Headlines, Breaking Research, Packard Center News
The Answer ALS data portal seeks to empower researchers around the globe with the data needed to finally answer ALS.
To see the video tribute
May 11
Breaking Research
The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease
Rea entire press release on
Nov 5
ALS Headlines, Breaking Research, Donor Stories, Ice Bucket Challenge, Packard Center News
Molecular differences between C9orf72 mutation-associated and sporadic ALS